NCT02882854View on ClinicalTrials.gov

Guanfacine for PONV and Pain After Sinus Surgery

NACompletedINTERVENTIONAL
Enrollment

84

Participants

Timeline

Start Date

November 30, 2016

Primary Completion Date

February 28, 2017

Study Completion Date

February 28, 2017

Conditions
Postoperative Nausea and VomitingPain, Postoperative
Interventions
DRUG

Guanfacine

Patients will receive 1 mg of guanfacine to take orally.

DRUG

Placebo

Patients will receive a placebo containing no drug that appears similarly to guanfacine to take orally.

Trial Locations (1)

37212

Vanderbilt University Medical Center, Nashville

All Listed Sponsors
lead

Vanderbilt University Medical Center

OTHER

NCT02882854 - Guanfacine for PONV and Pain After Sinus Surgery | Biotech Hunter | Biotech Hunter